We also evaluated the expression of ALDH1A3 and CD44, markers for breast cancer stem cells, in both control and RAB4A knockdown cells, and in the RAB4A knockdown cells that concurrently express either RAC1WT or RAC1CA. The gene discussed is CD44; the disease is breast carcinoma.